174 related articles for article (PubMed ID: 7585847)
1. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
Katsu K; Yabe S
Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
[TBL] [Abstract][Full Text] [Related]
2. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
Decktor D; Houle JM; Pierce CH
Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
[TBL] [Abstract][Full Text] [Related]
3. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
Bruley des Varannes S; Duquesnoy C; Mamet JP; Slama A; Galmiche JP; Scarpignato C
Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
[TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Szabó IL; Czimmer J; Szolcsányi J; Mózsik G
Curr Pharm Des; 2013; 19(1):84-9. PubMed ID: 22946903
[TBL] [Abstract][Full Text] [Related]
5. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
6. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
8. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
9. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers.
Smout AJ; Jonkman JH; Peeters PA; De Bruin H
Aliment Pharmacol Ther; 1995 Feb; 9(1):51-6. PubMed ID: 7766744
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
Amsden GW; Goss TF; Harrison NJ; D'Andrea DT; Schentag JJ
J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.
Mallat A; Roudot-Thoraval F; Bergmann JF; Trout H; Simonneau G; Dutreuil C; Blanc LE; Dhumeaux D; Delchier JC
Br J Clin Pharmacol; 1994 Feb; 37(2):208-11. PubMed ID: 7910473
[TBL] [Abstract][Full Text] [Related]
13. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
Gardner JD; Ciociola AA; Robinson M; McIsaac RL
Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
[TBL] [Abstract][Full Text] [Related]
17. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
[TBL] [Abstract][Full Text] [Related]
18. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
Hamilton MI; Sercombe J; Pounder RE
Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
[TBL] [Abstract][Full Text] [Related]
19. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[TBL] [Abstract][Full Text] [Related]
20. Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man.
von Kleist D; Gräf KJ; Dougherty FC; Hampel KE
Hepatogastroenterology; 1981 Aug; 28(4):210-2. PubMed ID: 6115806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
